This article lays out the argument for tackling heart disease with doses of condriten sulphate. This supplement has become well known as a treatment for arthritic pain and has become readily available.
Inasmuch as 90% of all men have developed circulatory issues with detectable plaques by the age of sixty and that women are about a decade behind, it behooves us to pursue corrective measures.
The human animal appears to lose the ability to produce sufficient natural molecules as we age and this deficiency produces or at least aggravates natural conditions such as joint wear. That is why condriten sulphate supplementation is so useful for arthritis.
Other molecules such as vitamin C are simply not produced as part of a genetic defect in humanity and guinea pigs.
The take home here is that a safe supplement is clearly able to accelerate natural healing in our bodies and this reverses the damage caused by circulatory disease and the scaring caused by heart attacks.
Recall that the medical profession gives up on the reversal of scar tissue. This is simply untrue. Given enough time and enough condriten sulphate and enough stem cells, there is plenty of evidence that scaring can be mostly eliminated. I personally had a nasty scar as a teen ager that today is unnoticeable and must be looked for.
The further take home lesson is that an individual past prime needs to supplement with condriten sulphate to simply support his internal healing system. The reports here suggest that 1500 mg per day will be ample.
The Man Who Cured Heart Disease With a Natural Molecule, 20 Years Before Cholesterol Drugs!
by Bill Sardi
His name: Dr. Lester Morrison.
His qualifications: Director and Research Professor, Institute for Arteriosclerosis Research, Loma Linda University , School of Medicine
Author: Coronary Heart Disease and the Mucopolysaccharides (1974, Charles C. Thomas)
In 1982 Dr. Morrison wrote: "I am Lester Morrison MD, and I have been a doctor for over 50 years. Much of that time has been devoted to finding a way to stop heart disease, which killed my mother, my father and several other members of my family and remains the number one killer in the U.S. and other developed countries."
Dr. Morrison provided compelling evidence in the 1960s that heart and blood vessel disease could be reversed and prevented with natural molecules, particularly chondroitin sulfate. This was over 20 years prior to the advent of the first cholesterol-reducing statin drug, Mevacor (1987).
Dr. Morrison writes that his ideas involving heart disease went back as far as 1942. He first began is his research using natural molecules to heal damaged hearts and arteries.
Dr. Morrison’s research was published in no less than 8 different medical journals. He began his studies in the 1940s, working with choline, a natural component of lecithin.
He later conceived of the idea that gelatinous material, then known as mucopolysaccharides, today known as glycosaminoglycans, could heal damaged hearts and arteries. His work involved chondroitin sulfate, a molecule that is a normal component of the connective tissue in the body. Dr. Morrison calls it "the glue of life."
He noted that chondroitin is the "coronary artery’s first line of defense against invasion by foreign substances,"such as cholesterol, bacteria and tumor cells. Chondroitin contributes to the elasticity of the blood vessels.
In cross section photos of coronary arteries, Dr. Morrison showed what a coronary artery looked in when an animal was fed a high-fat/cholesterol diet (left), revealing almost complete obstruction of the artery, and then when chondroitin sulfate was added to animal diets. The artery appears normal (right).
Left: Heart from rodent following heart attack (white area is scar tissue).
Right: Heart from rodent fed chondroitin sulfate, following heart attack.
Heparin is often administered to fresh heart attack patients to inhibit blood clots. The above photos demonstrate the superiority of chondroitin sulfate over heparin. Dr. Morrison said, "chondroitin did the job just as well as heparin, and the effect lasted longer. The anti-clotting property of heparin only lasts about 5 hours. In animal studies, chondroitin prolonged anti-clotting for up to two full days."
It was time for Dr. Morrison to begin treating live human subjects with chondroitin. Here are the startling results of his first studies.
More recent studies confirm Dr. Morrison’s earlier findings, that chondroitin sulfate is important in healing following a heart attack. Yet nothing is said of Dr. Morrison’s incredible discoveries decades prior.
Case presentations
Convincing evidence is also provided by Dr. Morrison with the presentation of individual cases, treated with chondroitin sulfate. Here is the data presented in three individual subjects.
Case No. 1
Male, age 68
Previous heart attack 1949
Diagnosis in 1965: artery disease, high blood pressure, coronary artery (heart) disease
Multiple cerebro-vascular incidents (impairment of oxygen to the brain, "mini strokes"); visual impairment; disorientation; exhaustion; difficulty speaking; needs assistance to walk or stand; severe vertigo (imbalance); fainting (black outs); blood pressure 170/125; takes 5 drugs and a vitamin pill.
Began 10,000 milligrams of oral chondroitin sulfate in May, 1966, tapered to 3000 mgs after 4 months and 1500 mgs after 5 months. After 2 months, "dramatic persistent improvement noted." All black-outs ceased; remarkable improvement in vision; able to walk without assistance; able to walk 6 miles each morning; notable hair growth.
Case No. 2
Female, age 59
Diagnosis in 1966: coronary artery disease with angina (chest pain); rheumatoid and osteoarthritis
Chest pain radiating to right shoulder for 3 years accompanied by shortness of breath, exhaustion, fright; symptoms relieved by rest; blood pressure 118/74; ankle swelling. Takes vitamin E, lecithin, valium, nitroglycerine, multivitamin, thyroid, arthritis drug.
Began 6000 milligrams of oral chondroitin sulfate in June of 1966, tapered to 1500 mg by December, 1966.
Two months following chondroitin: "very marked clinical improvement; complete disappearance of angina chest pain; began swimming, walking. Remarkable increase in vitality."
Case No. 3
Male, age 77
Diagnosis: Heart attack (healed), general artery disease, high blood pressure, prostate enlargement, "heart pounding"and skipped heartbeats; weakness, shortness of breath on exertion, loss of memory, insomnia, nervousness; blood pressure 160/100.
Previous treatments: Digitalis, blood pressure drugs, lecithin, vitamin supplements.
Began 6000 milligrams of oral chondroitin sulfate in June of 1966, tapered to 1500 mgs by Oct. 1966.
By Sept. 1966 patient reported he "feels wonderful"; disappearance of fatigue, debility, nervousness, weakness on exertion; no skipped heart beats; bushy hair growth on head, black hair replacing white hair; cancellation of planned prostate surgery.
Two recent experiences come to mind in regard to chondroitin sulfate and post-heart attack patients.
A man living in a remote part of eastern Washington State
In another instance, a 64-year-old man, who had experienced four prior heart attacks, which were evident on his electrocardiogram (EKG), took 1500 milligrams of chondroitin sulfate for a few months, then returned to a follow-up EKG in preparation for hernia surgery. Surprisingly, his EKG showed no evidence of a prior heart attack. The EKG technician thought his name had mistakenly been marked on an EKG of a healthy patient, so the EKG test was repeated, with the same result. This man has no more chest pain and is bicycling and hiking at a performance level uncharacteristic of a person his age.
The heart is slow to heal following a heart attack. Cell renewal is slow. Heart muscle tissue remains scarred (fibrotic). The provision of supplemental chondroitin sulfate appears to accelerate healing following a heart attack and would be a simple and unproblematic approach to regaining heart health following a heart attack. For the healthy, supplemental chondroitin sulfate would keep arterial plaque from developing altogether.
Since chondroitin also inhibits arterial calcification and cholesterol plaque as well as formation of blood clots, it becomes a comprehensive plaque and clot buster, proven in forgotten human studies. Chondroitin sulfate alone should be preferred over glucosamine, which requires a number of nutritional precursors before it can be converted to chondroitin.
References:
- Angiology. 1973 May; 24(5):269–87
- Coronary heart disease: reduction of death rate by chondroitin sulfate A. Morrison LM, Enrick N.
- Experientia. 1972 Dec 15; 28(12):1410–1
- Absence of naturally occurring coronary atherosclerosis in squirrel monkeys treated with chondroitin sulfate A.Morrison LM, Bajwa GS.
- Atherosclerosis. 1972 Jul–Aug; 16(1):105–18.
- Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet. Morrison LM, Bajwa GS, Alfin-Slater RB, Ershoff BH.
- Angiology. 1971 Mar; 22(3):165–74
- Reduction of ischemic coronary heart disease by chondroitin sulfate A. Morrison LM.
- Experimental Medicine Surgery. 1970; 28(2):188–93
- Prolongation of the plasma thrombus formation time of dogs administered chondroitin sulfates A and C. Morrison LM, Bajwa GS, Ershoff BH.
- J Am Geriatric Society 1969 Oct; 17(10):913–23
- Response of ischemic heart disease to chondroitin sulfate-A. Morrison LM.
- Experimental Medicine Surgery. 1969; 27(3):278–89
- The prevention of coronary arteriosclerotic heart disease with chondroitin sulfate A: preliminary report. Morrison LM, Branwood AW, Ershoff BH, Murata K, Quilligan JJ Jr, Schjeide OA, Patek P, Bernick S, Freeman L, Dunn OJ, Rucker P.
- J American Geriatric Society. 1968 Jul; 16(7):779–85
- Treatment of coronary arteriosclerotic heart disease with chondroitin sulfate-A: preliminary report. Morrison LM.
- Experimental Medicine Surgery. 1967; 25(1):61–71
- Treatment of atherosclerosis with acid mucopolysaccharides. Morrison LM, Quilligan JJ Jr, Murata K, Schjeide OA, Freeman L, Ershoff BH.
- Circulation Research. 1966 Aug; 19(2):358–63
- Prevention of atherosclerosis in sub-human primates by chondroitin sulfate A. Morrison LM, Murata K, Quilligan JJ Jr, Schjeide OA, Freeman L.
January 28, 2010
Bill Sardi [send him mail] is a frequent writer on health and political topics. His health writings can be found at www.naturalhealthlibrarian.com. He is the author of
Copyright © 2010 Bill Sardi Word of Knowledge Agency, San Dimas , California
